Novartis Pharma Services Romania S.R.L., a subsidiary of the global healthcare leader Novartis, is headquartered in Romania and operates extensively across Eastern Europe. Founded in 1996, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines and advanced therapies that address unmet medical needs. Specialising in areas such as oncology, cardiology, and immunology, Novartis Pharma Services Romania is renowned for its commitment to research and development, delivering unique products that enhance patient outcomes. The company has achieved significant milestones, including the launch of groundbreaking treatments that have transformed patient care. With a strong market position, Novartis Pharma Services Romania continues to contribute to the healthcare landscape, driven by a mission to improve and extend people's lives through science and innovation.
How does Novartis Pharma Services Romania S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Novartis Pharma Services Romania S.R.L.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Novartis Pharma Services Romania S.R.L. currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family, with its climate commitments and initiatives cascading from its parent organisation, Novartis AG. Novartis AG has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and commitments to renewable energy through the RE100 initiative. These initiatives reflect a strong commitment to reducing carbon emissions across its operations, although specific reduction targets for Novartis Pharma Services Romania S.R.L. have not been detailed. As a current subsidiary of Novartis AG, the Romanian entity aligns with the overarching sustainability goals of its parent company, which include significant efforts to mitigate climate impact and enhance environmental stewardship. While specific emissions data for Novartis Pharma Services Romania S.R.L. is not available, the company's alignment with Novartis AG's climate strategies indicates a commitment to sustainability and responsible environmental practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 583,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 922,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Novartis Pharma Services Romania S.R.L.'s Scope 3 emissions, which decreased by 5% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novartis Pharma Services Romania S.R.L. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.